Navigation Links
Scarguard Labs, LLC Appoints Richard E. Pino as CFO
Date:1/14/2009

GREAT NECK, N.Y., Jan. 14 /PRNewswire/ -- Scarguard Labs, LLC, a closely held company specializing in the treatment of scars and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced it has appointed Richard E. Pino as Chief Financial Officer. He will be responsible for the Company's finance, accounting, and treasury functions and will report to Chief Executive Officer, Joel Studin, MD.

Prior to his appointment, Mr. Pino served as Chief Financial Officer / Chief Operating Officer for EcoSys Management LLC, a leader in enterprise project and operations financial management solutions. While there, Mr. Pino was responsible for overall operations: Finance, HR, Legal and Facilities. Previously, Mr. Pino was the Chief Financial Officer for The Relegence Corporation, which became a wholly-owned subsidiary of AOL, a TimeWarner Company during Pino's tenure.

From 2001 through 2005, Pino was the CFO for Frontline Communications International, Inc. where he was responsible for overall operations as well as overseeing outside accounting, tax and legal firms. Prior to 2001, Mr. Pino held various financial positions in of the following industries: Telecom, investment banking and media. He currently serves in a financial capacity on the boards of several non-profit organizations, including The Brooklyn Philharmonic and the Museum of Biblical Art.

Mr. Pino received his BA from St. Francis College in 1990 and his MBA from Adelphi University in 1993.

Speaking of Mr. Pino's appointment, Dr. Studin said, "We couldn't be happier that Richard agreed to join our Company. His experience covers all aspects of the finance, treasury and accounting roles, and includes strategic planning, mergers and acquisitions, all roles that he will fulfill while at Scarguard. He will be a key part of Scarguard's growth as a company."

About Scarguard Labs, LLC.

Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed product for scars in plastic surgery offices since 2001. In addition, it can be found in most pharmacies, drug distributors and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs in the marketplace, or in varying stages of development. For more information, please visit our website at www.scarguard.com

    Company Contact:
    Richard E. Pino
    Chief Financial Officer /Investor Relations
    Scarguard Labs, LLC
    516-482-8050
    Richard@scarguard.com

    Investor Relations:
    John McNamara
    Cameron Associates
    (212) 245-8800 Ext. 205
    john@cameronassoc.com


'/>"/>
SOURCE Scarguard Labs, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
2. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
3. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
4. Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board
5. Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines
6. ev3 Inc. Appoints Shawn McCormick as New Sr. Vice President and Chief Financial Officer
7. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
8. Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business
9. eDiets.com(R) Appoints Kevin N. McGrath as President and CEO
10. Bon Secours Charity Health System Appoints Terence M. O'Brien as Chief Executive Officer
11. Bat Saliva-Based Stroke Drug Disappoints in Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Park, KS (PRWEB) , ... January 18, 2017 ... ... managed firm offering asset protection and financial planning services to families and business ... a charity event aimed at supporting children with developmental disabilities. , The Lakemary ...
(Date:1/18/2017)... ... January 18, 2017 , ... The Hear the ... project with the donation of cochlear implants. In February 2017, the first three ... a fair chance of leading an independent life. This engagement builds on the ...
(Date:1/17/2017)... ... 2017 , ... Anesthesia Progress – Everyone wants less pain during ... option for each patient. Dentists have several general anesthesia alternatives and finding the right ... the Tokyo Dental College in Tokyo, Japan wanted to find out which anesthetic was ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... , The company, owned and operated by Ed Stroup, was created to ... price with the highest level of customer service. Healthful Balance products can be ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... ... County, as well as Palm Desert, is opening a new office in San ... deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017 EU5 Glucose Monitoring Market ... report, "EU5 Glucose Monitoring Market Outlook to 2022", provides ... The report provides value, in millions of US dollars, ... segments - Blood Glucose Meters, Blood Glucose Test Strips ... and distribution shares data for each of these market ...
(Date:1/17/2017)... 17, 2017 The interventional radiology products market ... from USD 6.35 billion in 2016, at a CAGR ... of this market are rising incidence of chronic diseases, ... surgeries. The global interventional radiology products market ... On the basis of type, the stents segment is ...
(Date:1/17/2017)... -- The Global Nebulizers Market is poised to grow ... decade to reach approximately $1698.68 million by 2025. Some ... include rapidly growing demand in emerging regions, increasing use ... and online marketing strategies by key players. ... pneumatic nebulizers, ultrasonic nebulizers and mesh nebulizers. Pneumatic nebulizers ...
Breaking Medicine Technology: